Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jan
24
2017
PTO Litigation Center Report – January 24, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
9
2017
PTO Litigation Report – February 9, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sep
29
2014
PTO Litigation Center Report – September 29, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Oct
10
2014
PTO Litigation Center Report – October 10, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Apr
11
2017
PTO Litigation Report – April 11, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Apr
20
2017
PTO Litigation Report – April 20, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Nov
4
2014
The Era of Generic Biologic Drugs Has Officially Begun: An Update on U.S. Biosimilars [VIDEO] Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
4
2017
PTO Litigation Report – May 4, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Nov
6
2014
PTO Litigation Center Report – November 6, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Nov
10
2014
PTO Litigation Center Report – November 10, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
30
2017
The Supreme Court Redefines Patent Exhaustion Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
23
2017
PTO Litigation Report – June 23, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
12
2014
PTO Litigation Center Report – December 12, 2014 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
29
2017
PTO Litigation Report – June 29, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
16
2014
USPTO Issues New Subject Matter Eligibility Examination Interim Guidelines – Abstract Idea Guidance Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
24
2017
PTO Litigation Report – July 24, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
16
2017
PTO Litigation Report – August 16, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jan
23
2015
PTO Litigation Center Report – January 23, 2015 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Mar
4
2015
PTO Litigation Center Report – March 4, 2015 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Mar
18
2015
PTO Litigation Center Report – March 18, 2015 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Apr
14
2015
PTO Litigation Center Report – April 14, 2015 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Apr
17
2015
BIO Files Brief in Support of Mandatory Notice Requirement in the BPCIA Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
1
2015
FDA Finalizes Guidance Documents on Biosimilarity Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sep
22
2017
PTO Litigation Report – September 22, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
2
2011
Federal Circuit Upholds the Patentability of Isolated DNA in Association for Molecular Pathology v. Myriad Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
22
2015
FDA releases additional draft guidance regarding implementation of BPCIA Sterne, Kessler, Goldstein & Fox P.L.L.C.
May
27
2015
PTO Litigation Center Report – May 27, 2015 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Oct
31
2017
Preparing European Priority Applications for Stronger U.S. Patents Sterne, Kessler, Goldstein & Fox P.L.L.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins